Most people know HPV causes cervical cancer. Fewer know it does the same thing to anal tissue — and that gay and bisexual men are at significantly elevated risk for anal cancer. Not something to catastrophise about. Something to manage actively.
The HPV → pre-cancer → cancer progression is slow. It can be interrupted at multiple points. Vaccination stops most of it from starting. Screening catches pre-cancer before it becomes cancer. Both tools exist and they work.
🔩 How HPV Becomes Anal Cancer
HPV (Human Papillomavirus) is one of the most common STIs — most sexually active people encounter it at some point. The majority of infections clear on their own. The problem is the minority that don't.
High-risk HPV strains — primarily HPV 16 and 18 — can cause cellular changes in the tissue they infect. In the anus, the pipeline looks like this:
- HPV infection — usually completely symptom-free, often unnoticed
- AIN (Anal Intraepithelial Neoplasia) — abnormal cell changes. Graded low-grade (AIN 1) to high-grade (AIN 2/3). High-grade is the pre-cancer stage.
- Anal cancer — squamous cell carcinoma. What screening aims to prevent.
The transition from infection to high-grade pre-cancer to invasive cancer typically takes years to decades. This is exactly why screening works — the window is long.
Why gay and bisexual men are at elevated risk:
- Receptive anal sex is an efficient HPV transmission route — meaning higher lifetime exposure
- HIV-positive gay men face significantly elevated risk due to immune suppression; HIV-negative gay men still face elevated risk compared to heterosexual men
- Gay and bisexual men develop anal cancer at rates roughly 20–40 times higher than heterosexual men overall. HIV-positive gay men face roughly 30 times the anal cancer risk of HIV-negative men.
Those numbers sound alarming. They're also exactly why proactive screening makes sense as part of regular sexual health management.
🛡️ Vaccination: The First Line of Prevention
If you haven't had the full Gardasil 9 course, this is the single most impactful thing you can do for your long-term anal cancer risk.
Gardasil 9 protects against HPV types 16, 18, 31, 33, 45, 52, and 58 — covering roughly 90% of anal and cervical cancers and 90% of genital warts.
Already sexually active? Still worth it. Vaccination protects against strains you haven't yet encountered. Partial protection is better than none.
Age limits: Approved up to age 45. Routine recommendation through age 26. If you're 27–45 and haven't been vaccinated, the anal cancer risk profile for gay men makes this a conversation worth having with your doctor specifically.
🟢 Screening: Who Needs It and How It Works
Vaccination doesn't address HPV infections you may already have. Screening is how you stay ahead of any pre-cancer changes already in progress.
Who should be screened:
The evidence is strongest for:
- HIV-positive gay men — highest risk group; most guidelines recommend annual screening
- HIV-negative gay men with a history of receptive anal sex — screening every 1–3 years is increasingly recommended
If you're HIV-positive, talk to your HIV clinic about anal cancer screening. Many clinics now offer this routinely.
How the tests work:
Anal Pap smear (anal cytology): A small swab samples cells from the anal canal. The sample is checked under a microscope for abnormal changes. Quick, not particularly uncomfortable, and done at a sexual health or HIV clinic.
A positive result — abnormal cells found — doesn't mean cancer. It triggers further investigation.
High-resolution anoscopy (HRA): The gold standard when a Pap smear comes back abnormal. A clinician uses a magnifying instrument to examine the anal canal in detail, looking for pre-cancer changes. Biopsies of suspicious areas can be taken during the same procedure.
HRA is more specialised — not every sexual health clinic offers it. HIV clinics and specialist colorectal departments are the most common settings.
How to ask for it:
"I'm a gay man with a history of receptive anal sex and I'd like to discuss anal cancer screening. I know it isn't standard everywhere, but I'd like to understand the options."
For HIV-positive patients, raise it directly at your HIV clinic.
⚠️ If Something Is Found: What AIN Actually Means
Getting told you have AIN is alarming if you don't know what it means. Here's the real picture:
Low-grade AIN (AIN 1): Very commonly clears on its own — similar to how most HPV infections resolve. Active monitoring (rescreening in 6–12 months) rather than immediate treatment is usually the recommendation.
High-grade AIN (AIN 2/3): This is the pre-cancer stage. Treatment is recommended to prevent it progressing to invasive cancer. Options include:
- Topical agents: Trichloroacetic acid (TCA) applied to the area, or imiquimod cream
- Ablation: Infrared coagulation or laser treatment to destroy the abnormal tissue
- Surgical excision for larger areas
All of these have high success rates. You are treating a pre-cancer — not a cancer.
If invasive cancer is found: Anal cancer caught at Stage I or II has over 80% five-year survival. Treatment is chemotherapy combined with radiotherapy — not usually surgery — and functional outcomes are generally good. This is why early detection matters enormously.
🔀 Symptoms Worth Flagging to a Clinician
You don't need to be anxious about anal cancer. But bring these to a doctor rather than self-reassuring:
- Persistent rectal bleeding (not just occasional spotting after rough sex)
- Pain in the anal canal that doesn't resolve within a few days
- A persistent lump or swelling in or around the anus
- Unexplained changes in bowel habits combined with anal discomfort
Most of the time these have mundane explanations — haemorrhoids, fissures, skin tags. But they warrant a check, not an assumption.
The reassuring bottom line: Vaccinated against HPV and engaging in regular screening? You've addressed both prevention and early detection. The pipeline from infection to cancer is long and interruptible. Most people engaged with their healthcare will never develop anal cancer.
Related: